Food News and Research

RSS

Alcatel-Lucent receives FDA clearance to market Alcatel-Lucent TeleHealth Manager in the US

Alcatel-Lucent today announced that the Alcatel-Lucent TeleHealth Manager, a secure and reliable remote patient monitoring solution, has been cleared by the U.S. Food and Drug Administration (FDA) for marketing in the United States.

4 Nov 2009

Reuters examines how much of G8 agriculture investment is new

Three billion of the $20 billion that G8 leaders promised to invest in agriculture in developing countries "appears to be new money, diplomats and sources close to the matter said on Tuesday," Reuters reports. "Most of that new money, up to $2 billion, is coming from the United States, according to two sources, one on the donor side and one on the recipient side," the news service writes.

4 Nov 2009

News outlets examine international efforts to contain H1N1

A WHO official on Tuesday backed the Afghan government's decision to declare H1N1 (swine flu) a health emergency, forcing the closure of all schools in the country for three weeks in an effort to contain the virus, IRIN reports.

4 Nov 2009

"Alternate-day fasting" reduces body weight and improves cardio health: Study

Restricting daily calorie intake is a common plan to help obese and overweight people slim down to healthier weights. But the regime requires a daily 15 to 40 percent calorie reduction, which makes sticking to the diet hard for many.

4 Nov 2009

GenVec receives FDA orphan drug designation for TNFerade

GenVec, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to TNFerade(TM) for the treatment of pancreatic cancer.

4 Nov 2009

Watson Pharmaceuticals announces third quarter 2009 financial results

Watson Pharmaceuticals, Inc. today reported net income of $63.0 million, or $0.55 per diluted share for the third quarter ended September 30, 2009. Excluding special items as detailed in the reconciliation table below, adjusted net income for the third quarter was $76.1 million, or $0.66 per diluted share, an increase of $22.1 million or 41 percent over the adjusted net income for the third quarter ended September 30, 2008. As detailed in the attached reconciliation table, adjusted EBITDA for the third quarter was $178.4 million.

4 Nov 2009

Shire receives FDA Priority Review for velaglucerase alfa NDA

Shire plc, the global specialty biopharmaceutical company, today announced that the United States Food and Drug Administration (FDA) has granted Priority Review for the New Drug Application (NDA) for velaglucerase alfa, the company's enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease.

4 Nov 2009

USPTO issues Notice of Allowance for Transcept Pharmaceuticals' Intermezzo

Transcept Pharmaceuticals, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. patent application no. 11/833,323, which covers the use of Intermezzo® (zolpidem tartrate sublingual tablet), the lead Transcept product candidate. Once issued, this patent will expire in February 2025.

4 Nov 2009

CPEX Pharmaceuticals announces third-quarter results; reports net loss of $872,000

CPEX Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2009. For the quarter CPEX reported revenues of $5.0 million and a net loss of $872,000.

4 Nov 2009

Cipher Pharmaceuticals announces financial results for the third quarter of 2009

Cipher Pharmaceuticals Inc. today announced its financial and operational results for the three and nine months ended September 30, 2009.

4 Nov 2009

Avoiding foods high in AGE toxins can reduce inflammation and restore the body's natural defenses

Researchers from Mount Sinai School of Medicine report that cutting back on the consumption of processed and fried foods, which are high in toxins called Advanced Glycation End products (AGEs), can reduce inflammation and actually help restore the body's natural defenses regardless of age or health status. These benefits are present even without changing caloric or nutrient intake.

4 Nov 2009

FDA holds meeting on issues related to transparency at the agency

The U.S. Food and Drug Administration will seek comments on three specific issues related to transparency at the agency during a daylong public meeting on Tuesday, Nov. 3, 2009.

4 Nov 2009

Cutting back on the consumption of AGEs can reduce inflammation, report researchers

4 Nov 2009

Eating a meal quickly curtails the release of hormones in the gut and can lead to overeating

According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), eating a meal quickly, as compared to slowly, curtails the release of hormones in the gut that induce feelings of being full. The decreased release of these hormones, can often lead to overeating.

4 Nov 2009

Eat slowly to avoid overeating

4 Nov 2009

The Children’s Hospital leads the charge against childhood obesity

The Children’s Hospital is leading the charge against childhood obesity, a problem that is impacting more and more families across the country. Experts from The Children’s Hospital offer a pediatric perspective on proactive steps parents can take to ensure their children maintain nutritious diets and healthy, active lifestyles.

4 Nov 2009

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company’s CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.

3 Nov 2009

Biomoda receives U.S patent for cytology-based screening assay

Biomoda, Inc. (OTCBB: BMOD), an Albuquerque-based cancer diagnostics company, announces that it has received notice of allowance for a U.S. Patent protecting the proprietary formula for the composition that binds to cancer cells which is utilized in Biomoda’s screening assay for the early detection of cancer

3 Nov 2009

Health Canada approves the marketing of BioMimetic Therapeutics' Augment Bone Graft

BioMimetic Therapeutics, Inc. announced today that it has received approval from Health Canada to begin the marketing of its lead orthopedic product, Augment™ Bone Graft, as an alternative to the use of autograft in midfoot, hindfoot and ankle fusion indications in Canada.

3 Nov 2009

Christian Science Monitor examines focus on combatting hunger

The Christian Science Monitor looks at one idea about why hunger is receiving a lot of attention in the international arena. Kanayo Nwanze, the Kenyan "who recently became president of the United Nations' International Fund for Agricultural Development (IFAD) says globalization has made the hunger and rural poverty that always pulled on the heartstrings an international security issue," according to the publication.

3 Nov 2009

Food News and Research

Alcatel-Lucent receives FDA clearance to market Alcatel-Lucent TeleHealth Manager in the US

Reuters examines how much of G8 agriculture investment is new

News outlets examine international efforts to contain H1N1

"Alternate-day fasting" reduces body weight and improves cardio health: Study

GenVec receives FDA orphan drug designation for TNFerade

Watson Pharmaceuticals announces third quarter 2009 financial results

Shire receives FDA Priority Review for velaglucerase alfa NDA

USPTO issues Notice of Allowance for Transcept Pharmaceuticals' Intermezzo

CPEX Pharmaceuticals announces third-quarter results; reports net loss of $872,000

Cipher Pharmaceuticals announces financial results for the third quarter of 2009

Avoiding foods high in AGE toxins can reduce inflammation and restore the body's natural defenses

FDA holds meeting on issues related to transparency at the agency

Cutting back on the consumption of AGEs can reduce inflammation, report researchers

Eating a meal quickly curtails the release of hormones in the gut and can lead to overeating

Eat slowly to avoid overeating

The Children’s Hospital leads the charge against childhood obesity

Absorption Systems awarded FDA SBIR grant for developing its CellPort Technologies testing platform

Biomoda receives U.S patent for cytology-based screening assay

Health Canada approves the marketing of BioMimetic Therapeutics' Augment Bone Graft

Christian Science Monitor examines focus on combatting hunger

Enhancing confidence in chemical ionization spectrometry data eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News